RT @fezziwig2008: @popastock @dannydyn1 A cohort of 41 relapsed/refractory pts given SC daratumumab w/ $HALO rHuPH20- In this small P1b ser…
New developments in the treatment of multiple myeloma - clinical utili | BTT @DovePress https://t.co/2PbbRHHxBC
RT @ImmunePC_Papers: PC | #Biologics New developments in the treatment of multiple myeloma - clinical utility of daratumumab. https://t.co/…
PC | #Biologics New developments in the treatment of multiple myeloma - clinical utility of daratumumab. https://t.co/xIaVU9CxPn
See our review of Daratumumab in #MYELOMA @DovePress https://t.co/6G86g8RHp3
RT @MichaelodwyerMD: New developments in the treatment of multiple myeloma - clinical utili | BTT @DovePress https://t.co/6G86g8RHp3
New developments in the treatment of multiple myeloma - clinical utili | BTT @DovePress https://t.co/6G86g8RHp3